BACTERIAL PROTEINS IN RECOMBINATIONAL DNA REPAIR

重组 DNA 修复中的细菌蛋白

基本信息

  • 批准号:
    2883027
  • 负责人:
  • 金额:
    $ 20.54万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1996
  • 资助国家:
    美国
  • 起止时间:
    1996-03-01 至 2000-06-30
  • 项目状态:
    已结题

项目摘要

The goals of this proposal is to provide a detailed understanding of the activities of five proteins from Escherichia coli that are involved in recombinational DNA repair and homologous genetic recombination. These are the RuvA, RuvB, RecF, RecO, and RecR proteins. Some mutations in each of the corresponding genes lead to recombination defects in certain genetic backgrounds. The same mutations confer sensitivity to DNA damaging agents in an otherwise wild type background. The RecF, O, and R proteins are believed to act early in recombinational processes. One function identified to date is to facilitate RecA protein binding to SSB-coated single-stranded DNA. The amino acid sequence of each of these proteins features a consensus nucleotide binding site, although NTP hydrolysis has not been reported and little is known about the function of nucleotides in any activity these proteins may have. We propose to characterize the DNA and NTP binding properties of the RecF, O, and R proteins in detail. We will also examine the effects of these proteins on RecA activities in vitro. If RecA forms mixed filaments with these proteins or any subset of them, we will focus on defining the activities of the filaments so modified. The RuvA and RuvB proteins are believed to contribute to the processing of branched recombination intermediates generated by RecA protein. These proteins promote DNA branch migration in vitro which could contribute to the rapid generation of hybrid DNA during recombination. The proteins exhibit a limited DNA helicase activity, and RuvB protein hydrolyzes ATP. In combination with RecA, they promote the bypass of regions of heterology that are too long to be bypassed by RecA protein alone. If a barrier cannot be bypassed, these proteins promote an efficient reversal of RecA- mediated DNA strand exchange. One function of these proteins may be to act as a kind of anti-recombination system, to process or reverse stalled Holliday structures that may result from potentially deleterious intragenomic recombination events. Our studies on RuvA and B will focus in part on the characterization of DNA binding and ATP hydrolysis to elucidate the mechanism by which these proteins translocate on the DNA. We will also examine the mechanism by which RuvA and B process stalled DNA branches generate by RecA, as a model for RuvA and B action in all recombination processes.
本提案的目标是提供对

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Michael M. Cox其他文献

Using Real-Time, Single-Molecule Experiments to Monitor Reca-Mediated Pairing and Strand Exchange Reactions at Various Nucleotide States
  • DOI:
    10.1016/j.bpj.2010.12.1262
  • 发表时间:
    2011-02-02
  • 期刊:
  • 影响因子:
  • 作者:
    Hsiu-Fang Fan;Michael M. Cox;Hung-Wen Li
  • 通讯作者:
    Hung-Wen Li
Abbau von Fettsäuren
阿巴乌·冯·费特绍伦
  • DOI:
  • 发表时间:
    2011
  • 期刊:
  • 影响因子:
    0
  • 作者:
    David L. Nelson;Michael M. Cox
  • 通讯作者:
    Michael M. Cox
Respiratory disease, behavior, and survival of mountain goat kids
山羊幼崽的呼吸道疾病、行为和生存
  • DOI:
    10.1002/jwmg.21470
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    2.3
  • 作者:
    J. Blanchong;Christopher A. Anderson;N. Clark;R. Klaver;P. Plummer;Michael M. Cox;Caleb McAdoo;P. Wolff
  • 通讯作者:
    P. Wolff
Glycolyse und der Katabolismus der Hexosen
糖酵解和六糖分解代谢
  • DOI:
  • 发表时间:
    2001
  • 期刊:
  • 影响因子:
    0
  • 作者:
    David L. Nelson;Michael M. Cox
  • 通讯作者:
    Michael M. Cox
Translocated to the fringe: genetic and niche variation in bighorn sheep of the Great Basin and northern Mojave deserts
转移到边缘:大盆地和莫哈韦沙漠北部大角羊的遗传和生态位变异
  • DOI:
    10.1111/ddi.12329
  • 发表时间:
    2015
  • 期刊:
  • 影响因子:
    4.6
  • 作者:
    Jason L. Malaney;C. Feldman;Michael M. Cox;P. Wolff;J. Wehausen;M. Matocq
  • 通讯作者:
    M. Matocq

Michael M. Cox的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Michael M. Cox', 18)}}的其他基金

Characterization of the RRS: a new chromosomal structural element in E. coli
RRS 的表征:大肠杆菌中的一种新染色体结构元件
  • 批准号:
    10752809
  • 财政年份:
    2023
  • 资助金额:
    $ 20.54万
  • 项目类别:
Creation and Repair of Postreplicative DNA Gaps
复制后 DNA 缺口的产生和修复
  • 批准号:
    10614989
  • 财政年份:
    2019
  • 资助金额:
    $ 20.54万
  • 项目类别:
Creation and Repair of Postreplicative DNA Gaps
复制后 DNA 缺口的产生和修复
  • 批准号:
    10400046
  • 财政年份:
    2019
  • 资助金额:
    $ 20.54万
  • 项目类别:
Creation and Repair of Postreplicative DNA Gaps
复制后 DNA 缺口的产生和修复
  • 批准号:
    10152643
  • 财政年份:
    2019
  • 资助金额:
    $ 20.54万
  • 项目类别:
Molecular basis of ionizing radiation resistance
抗电离辐射的分子基础
  • 批准号:
    9239223
  • 财政年份:
    2017
  • 资助金额:
    $ 20.54万
  • 项目类别:
Molecular basis of ionizing radiation resistance
抗电离辐射的分子基础
  • 批准号:
    9923665
  • 财政年份:
    2017
  • 资助金额:
    $ 20.54万
  • 项目类别:
GENETIC RECOMBINATION & GENOME REARRANGEMENTS
基因重组
  • 批准号:
    7745837
  • 财政年份:
    2009
  • 资助金额:
    $ 20.54万
  • 项目类别:
The Biochemistry of Genetic Recombination/RecA Protein
基因重组/RecA 蛋白的生物化学
  • 批准号:
    7929939
  • 财政年份:
    2009
  • 资助金额:
    $ 20.54万
  • 项目类别:
Double strand DNA break repair in D. radiodurans
D. radiodurans 中的双链 DNA 断裂修复
  • 批准号:
    7171806
  • 财政年份:
    2005
  • 资助金额:
    $ 20.54万
  • 项目类别:
Double strand DNA break repair in D. radiodurans
D. radiodurans 中的双链 DNA 断裂修复
  • 批准号:
    6858270
  • 财政年份:
    2005
  • 资助金额:
    $ 20.54万
  • 项目类别:

相似海外基金

DNA repair pathway coordination during damage processing
损伤处理过程中 DNA 修复途径的协调
  • 批准号:
    10748479
  • 财政年份:
    2024
  • 资助金额:
    $ 20.54万
  • 项目类别:
CAREER: Mechanisms and consequences of epigenome-recruited DNA repair systems in plants
职业:植物中表观基因组招募的 DNA 修复系统的机制和后果
  • 批准号:
    2338236
  • 财政年份:
    2024
  • 资助金额:
    $ 20.54万
  • 项目类别:
    Continuing Grant
Multifaceted regulation of the DNA repair machinery and suppression of aberrant transcription by telomere proteins
DNA 修复机制的多方面调控和端粒蛋白异常转录的抑制
  • 批准号:
    2246561
  • 财政年份:
    2023
  • 资助金额:
    $ 20.54万
  • 项目类别:
    Standard Grant
Elucidation of the molecular link between DNA repair and mitochondrial nucleic acid metabolism
阐明DNA修复和线粒体核酸代谢之间的分子联系
  • 批准号:
    23K07078
  • 财政年份:
    2023
  • 资助金额:
    $ 20.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
DNA Repair State Machines
DNA 修复状态机
  • 批准号:
    EP/X027406/1
  • 财政年份:
    2023
  • 资助金额:
    $ 20.54万
  • 项目类别:
    Research Grant
Structural studies for understanding the mechanism of DNA repair in chromatin
了解染色质 DNA 修复机制的结构研究
  • 批准号:
    23H05475
  • 财政年份:
    2023
  • 资助金额:
    $ 20.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (S)
Biochemistry of Eukaryotic Replication Fork and DNA Repair
真核复制叉的生物化学和 DNA 修复
  • 批准号:
    10550045
  • 财政年份:
    2023
  • 资助金额:
    $ 20.54万
  • 项目类别:
Modeling the Responsiveness of Sensitive Populations to Genotoxic Agents Using DNA Repair Inhibitors
使用 DNA 修复抑制剂模拟敏感人群对基因毒性药物的反应性
  • 批准号:
    10734425
  • 财政年份:
    2023
  • 资助金额:
    $ 20.54万
  • 项目类别:
A role of balanced sex hormone in DNA repair in human melanocytes
平衡性激素在人类黑素细胞 DNA 修复中的作用
  • 批准号:
    10666307
  • 财政年份:
    2023
  • 资助金额:
    $ 20.54万
  • 项目类别:
Natural products inhibitors targeting homology-directed DNA repair for cancer therapy
针对癌症治疗的同源定向 DNA 修复的天然产物抑制剂
  • 批准号:
    10651048
  • 财政年份:
    2023
  • 资助金额:
    $ 20.54万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了